A nonequilibrium alchemical method for drug-receptor absolute binding free energy calculations: the role of restraints

28 February 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

In this paper we further develop a combined Hamiltonian replica exchange / non-equilibrium alchemical method for absolute binding free energies and test its performance on 11 ligands of the BRD4 bromodomain protein. We compare the results obtained with our approach with those obtained with other equilibrium and non-equilibrium alchemical methods showing their relative strengths, weaknesses, and limits. We show how using an enhanced sampling technique, before the alchemical transformations, allows to get accurate estimates of the binding free energies even when starting with sub-optimal initial binding poses (e.g. from docking). We also study the effect of different restraining mechanisms on the final result, and introduce a new "Loose-Tight" restraining algorithm. The method proves to strike a good balance between ease of use, automation, speed, and accuracy for absolute ligand binding free energy calculations and our scripts make it easy to integrate it into pre-existing computational drug discovery pipelines.

Keywords

absolute binding free energy
alchemical transformations
non equilibrium alchemical transformations
BRD4
bromodomain
vDSSB
virtual double system single box
Loose-Tight restraint
Loose Tight restraint

Supplementary materials

Title
Description
Actions
Title
Supporting informations
Description
Supporting informations of "A nonequilibrium alchemical method for drug-receptor absolute binding free energy calculations: the role of restraints"
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.